Symbol="IMCR"
AssetType="Common Stock"
Name="Immunocore Holdings Ltd"
Description="Immunocore Holdings Limited, an advanced stage biotechnology company, develops immunotherapies for the treatment of cancer, infectious and autoimmune diseases. The company is headquartered in Abingdon, the United Kingdom."
CIK="1671927"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="90 PARK DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, GB"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="3004176000"
EBITDA="-36627000"
PERatio="None"
PEGRatio="None"
BookValue="5.67"
DividendPerShare="0"
DividendYield="0"
EPS="-1.26"
RevenuePerShareTTM="3.543"
ProfitMargin="-0.252"
OperatingMarginTTM="-0.244"
ReturnOnAssetsTTM="-0.0711"
ReturnOnEquityTTM="-0.191"
RevenueTTM="165804000"
GrossProfitTTM="54113000"
DilutedEPSTTM="-1.26"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.982"
AnalystTargetPrice="81.85"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="27.83"
PriceToBookRatio="8.13"
EVToRevenue="25.36"
EVToEBITDA="-54.19"
Beta="0.603"
num_52WeekHigh="69.06"
num_52WeekLow="38.9"
num_50DayMovingAverage="58.28"
num_200DayMovingAverage="56.18"
SharesOutstanding="46225200"
DividendDate="None"
ExDividendDate="None"
symbol="IMCR"
open="65.00"
high="65.00"
low="62.87"
price="64.99"
volume="125291.00"
latest_trading_day="2023-07-11"
previous_close="64.74"
change="0.25"
change_percent="0.3862%"
aroon_positive_momentum_days="51"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="51"
Volume_recent_avg="242345"
Change_recent_avg="0.07"
Delta_recent_avg="2.46"
Variance_recent_avg="1.23"
Change_ratio_recent_avg="0.07"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="51"
Aroon_momentum_negative="49"
image_negative_thumbnail_id_1="497"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0108.jpeg"
image_negative_thumbnail_id_2="1159"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0193.jpeg"
image_neutral_thumbnail_id_1="432"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Neutral_Landscape_0019.jpeg"
image_neutral_thumbnail_id_2="556"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0043.jpeg"
image_positive_thumbnail_id_1="962"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0124.jpeg"
image_positive_thumbnail_id_2="605"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0103.jpeg"
image_professor_thumbnail_id_1="1195"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
image_professor_thumbnail_id_2="1185"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
